NorthStar Asset Management (New Jersey)’s AbbVie ABBV Stock Holding History

NorthStar Asset Management (New Jersey)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$806K	Sell	3,204 -69	-2%	-$14.8K	0.33%	48
2026 Q1	$712K	Sell	3,273 -686	-17%	-$152K	0.34%	48
2025 Q4	$905K	Buy	3,959 +9	+0.2%	+$2.05K	0.41%	44
2025 Q3	$915K	Buy	3,950 +10	+0.3%	+$2.04K	0.44%	41
2025 Q2	$731K	Buy	3,940 +67	+2%	+$12.5K	0.39%	46
2025 Q1	$811K	Sell	3,873 -146	-4%	-$28.4K	0.51%	36
2024 Q4	$714K	Sell	4,019 -286	-7%	-$52.6K	0.45%	40
2024 Q3	$850K	Sell	4,305 -91	-2%	-$17K	0.57%	34
2024 Q2	$754K	Sell	4,396 -101	-2%	-$16.7K	0.52%	37
2024 Q1	$819K	Buy	4,497 +90	+2%	+$15.5K	0.62%	34
2023 Q4	$683K	Buy	+4,407	New	+$642K	0.62%	36

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NorthStar Asset Management (New Jersey)'s ABBV Position: Q2 2026 in Review

NorthStar Asset Management (New Jersey) reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $14.8K and leaving 3,204 shares worth $806K. The position accounts for 0.33% of the portfolio, ranked #48.

NorthStar Asset Management (New Jersey) first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $915K in Q3 2025. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

NorthStar Asset Management (New Jersey) held 3,204 shares of AbbVie worth $806K as of Q2 2026.
NorthStar Asset Management (New Jersey) sold 69 AbbVie shares in Q2 2026, an estimated $14.8K.
AbbVie made up 0.33% of NorthStar Asset Management (New Jersey)'s portfolio in Q2 2026, its #48 holding.
NorthStar Asset Management (New Jersey) first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
NorthStar Asset Management (New Jersey)'s AbbVie position peaked at $915K in Q3 2025.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NorthStar Asset Management (New Jersey)'s 13F filing for Q2 2026, filed 5 Aug 2026.